Evidence map›Paper›PMID 42395003›Full record

ArticleJournal of ginseng research2026

Effect of diabetes on the efficacy and safety of

Xinya Li, Yuan Shen, Xiaoli Zhang, Xunming Ji, Haiqing Song, Ying Gao, Anxin Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of ginseng research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinya LiDepartment of Epidemiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Yuan ShenDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Xiaoli ZhangDepartment of Epidemiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Xunming JiDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Haiqing SongDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Ying GaoInstitute for Brain Disorders, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
Anxin WangDepartment of Epidemiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes is a risk factor of poor stroke outcomes. A randomized clinical trial has demonstrated that Methods: The PANDA (efficacy and safety of Results: In the modified intention-to-treat dataset, there were 722 patients with diabetes or treated hyperglycemia during hospitalization (369 in the Xuesaitong group and 353 in the placebo group) and 2244 patients without (1118 in the Xuesaitong group and 1126 in the placebo group). Among patients with diabetes or treated hyperglycemia during hospitalization, the proportion of patients with functional independence at 3 months was 83.20 % (n = 307) in the Xuesaitong group and 79.60 % (n = 281) in the placebo group (odds ratio, 1.27; 95 % confidence intervals [CI], 0.87-1.85; P = 0.215). Regarding patients without diabetes or treated hyperglycemia during hospitalization, the proportion was 91.32 % (n = 1021) in the Xuesaitong group and 83.21 % (n = 937) in the control group (OR, 2.12; 95 % CI, 1.64-2.76; P < 0.001; P for interaction = 0.027). The sensitivity analyses indicated similar significant results. Conclusion: In the PANDA trial, patients without, rather than with, diabetes or treated hyperglycemia during hospitalization received greater benefit from Xuesaitong soft capsules regarding functional independence at 3 months.

Indexed as

Antidiabetic drugsDiabetesIschemic strokePanax notoginseng saponinsXuesaitong soft capsules

Identifiers

PMID42395003
PMCPMC13323925

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.